Management Team
Executives
- ChairmanSimon WuEducation BS in Chemical Engineering, Tunghai University, TaiwanCurrent Position:
- Chairman, San Fu Chemical Co., Ltd., Taiwan
- Chairman, Li Fu Carbon Dioxide Co., Ltd., Taiwan
- Directors of the Boards, International Nitto Technology Co., Ltd.; Hongchen Enterprise Co., Ltd.; San Fu Global Co., Ltd.
Experience:-
- President & Vice Chairman, Air Products San Fu Co., Ltd.
- Manager & Director, Formosa Chemicals & Fibre Crop.
- Chairman, Industrial Gas Association of Taiwan.
- PresidentDaniel C.H. ChengEducation PhD in Chemical Engineering, University of Michigan, USA MS in Chemical Engineering, Oklahoma State University, USA BS in Chemical Engineering, Tunghai University, TaiwanExperience:
- President, PhytoHealth Corp.
- VP, Development Center for Biotechnology (DCB), Taiwan.
- General Director, Biotechnology & Pharmaceutical Industries Promotion Office (BPIPO), MOEA, Taiwan
- Science & Technology Advisor, Department of Industrial Technology, MOEA, Taiwan
- Founder, Chairman & President, Caleb Pharmaceuticals, Inc., Taiwan
- Senior Researcher & Manager, Laboratory of Controlled Release Technology, Union Chemical Laboratory, ITRI, Taiwan
- Adjunct Professor, Department of Chemical Engineering, Tunghai Univ., Taiwan
- Manager of R&D, Theratech, Inc. Salt Lake City, Utah, USA
- Chief Operating OfficerAlice HsuEducation MS in Nutritional Sciences, University of Illinois, USA MS in International Health, Johns Hopkins University, USA. BS in Nutrition and Health Sciences, Taipei Medical UniversityExperience:
- Senior Vice President, Clinical Technology Services and Consultations ,AlphaLife Sciences Singapore
- Vice President, Clinical Technology Services and Consultations, AlphaLife Sciences Shanghai
- Senior Director, PPD Shanghai China
- Senior Director, WuXi Clinical Development Services (Shanghai) CO.
- Project Director, Covance Clinical Development Services, Singapore
- Associate Clinical Project Manager, Quintiles Ltd., Taiwan
研發及行政團隊
- Director of Research and DevelopmentChih-Peng LiuEducation: MS & Ph.D. in Pharmacology, National Yang Ming University, Taiwan BS in Pharmacy, Taipei Medical College, TaiwanExperience:
- Deputy Division Director, Targeted Drug & Delivery Technology Division, BDL, ITRI, Taiwan
- Manager, Preclinical Drug Discovery Technology Department, BDL, ITRI, Taiwan
- Principal Researcher, BDL, ITRI, Taiwan
- Project Director of Technology Development Program, ITRI, Taiwan
- Director of Clinical OperationsNicole ShihEducation: MS in Toxicology, National Taiwan University, Taiwan BS in Nursing, National Taiwan University, TaiwanExperience:
- Product Development Lead, WuXi MedImmune Biopharmaceutical Co. Limited
- Director of Clinical Development and Portfolio Management, WuXi Clinical Development Services (Shanghai) CO.
- Clinical Project Manager, Quintiles Ltd., Taiwan
Scientific Advisory Board (SAB) for New Drug Development.
We have assembled a Scientific Advisory Board (SAB) composed of senior executives with extensive experience in R&D, clinical development, regulatory affairs, and marketing at leading global pharmaceutical companies, including Abbott, Bayer, Bristol Myers Squibb, Johnson & Johnson, Allergan, and Wyeth. This distinguished group brings a wealth of hands-on expertise in global drug development, providing strategic guidance to our executive leadership and R&D teams.